Showing results (1441-1450 of 1,479) with videos related to

Sort By:
Pageof 148
Nature Communications|June 26, 2021
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in KenyaIfedayo M O Adetifa, Sophie Uyoga, John N Gitonga, et al.
The Lancet. Oncology|February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumCorneel Coens, Madeline Pe, Amylou C Dueck, et al.
The Lancet. Microbe|February 26, 2026
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceKatherine E Gallagher, Fredrick Odiwour, Christian Bottomley, et al.
Breast (Edinburgh, Scotland)|February 13, 2025
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42Vesna Bjelic-Radisic, Fatima Cardoso, Joachim Weis, et al.
The Lancet. Oncology|November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trialTimothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.
JAMA|May 17, 2022
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics GuidelinesSamantha Cruz Rivera, Olalekan Lee Aiyegbusi, Jonathan Ives, et al.
Health Technology Assessment (Winchester, England)|November 25, 2021
Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCTAdam Devall, Justin Chu, Leanne Beeson, et al.
Influenza and Other Respiratory Viruses|September 26, 2023
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022E Wangeci Kagucia, Abdhala K Ziraba, James Nyagwange, et al.
Science (New York, N.Y.)|November 12, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donorsSophie Uyoga, Ifedayo M O Adetifa, Henry K Karanja, et al.
Clinical Trials (London, England)|August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trialsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
Pageof 148